Platelet transfusions for patients with haematological malignancies: Who needs them?

British Journal of Haematology

Volumn 154, Issue 4, 2011, Pages 425-440

  Estcourt, Lise J ^a   Stanworth, S J ^a   Murphy, M F ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Haematology; Platelet transfusion; Prophylaxis

Indexed keywords

ELTROMBOPAG; HEMOSTATIC AGENT; ROMIPLOSTIM; TRANEXAMIC ACID;

ACUTE LEUKEMIA; BLEEDING; BLOOD SAFETY; CLINICAL PRACTICE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEMATOLOGIC MALIGNANCY; HEMOSTASIS; HUMAN; PATHOGEN LOAD; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; EVIDENCE-BASED MEDICINE; HEMATOLOGIC NEOPLASMS; HEMORRHAGE; HUMANS; MIDDLE AGED; PATIENT SELECTION; PLATELET TRANSFUSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 80955177485     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08483.x     Document Type: Review

References (100)

1. Ajani, J.A., Welsh, S.R., Raber, M.N., Fields, W.S. & Krakoff, I.H. (1990) Comprehensive criteria for assessing therapy-induced toxicity. Cancer Investigation, 8, 141-153.
2. Apelseth, T.O., Bruserud, Ø., Wentzel-Larsen, T. & Hervig, T. (2010) Therapeutic efficacy of platelet transfusion in patients with acute leukemia: an evaluation of methods. Transfusion, 50, 766-775.
3. Azuma, H., Hirayama, J., Akino, M., Miura, R., Kiyama, Y., Imai, K., Kasai, M., Koizumi, K., Kakinoki, Y., Makiguchi, Y., Kubo, K., Atsuta, Y., Fujihara, M., Homma, C., Yamamoto, S., Kato, T. & Ikeda, H. (2009) Reduction in adveres reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol). Transfusion, 49, 214-218.
4. Beutler, E. (1993) Platelet transfusions: the 20, 000/uL trigger. Blood, 81, 1411-1413.
5. Blajchman, M.A., Senyi, A.F., Hirsh, J., Genton, E. & George, J.N. (1981) Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets. Journal of Clinical Investigation., 68, 1289-1294.
6. Blumberg, N., Spinelli, S.L., Francis, C.W., Taubman, M.B. & Phipps, R.P. (2009) The platelet as an immune cell - CD40 ligand and transfusion immunomodulation. Immunology Research, 45, 251-260.
7. British Committee for Standards in Haematology (BCSH) (2003) Guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 10-23.
8. British Committee for Standards in Haematology (BCSH) (2004) Transfusion guidelines for neonates and older children. British Journal of Haematology, 123, 433-453.
9. British Committee for Standards in Haematology (BCSH) (2007) Erratum to transfusion guidelines for neonates and older children. Available from:. Accessed 30 June 2010.
10. Cameron, B., Rock, G., Olberg, B. & Neurath, D. (2007) Evaluation of platelet transfusion triggers in a tertiary-care hospital. Transfusion, 47, 206-211.
11. Carr, R., Hutton, J.L., Jenkins, J.A., Lucas, G.F. & Amphlett, N.W. (1990) Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. British Journal of Haematology, 75, 408-413.
12. Cauwenberghs, S., Feijge, M.A.H., Theunissen, E., Heemskerk, J.W.M., van Pampus, E.C.M. & Curver, J. (2006) Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation. British Journal of Haematology, 136, 480-490.
13. Chapman, C.E., Stainsby, D., Jones, H., Love, E., Massey, E., Win, N., Navarrete, C., Lucas, G., Soni, N., Morgan, C., Choo, L., Cohen, H., Williamson, L.M., on behalf of the Serious Hazards of Transfusion Steering Group (2009) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion, 49, 440-452.
14. Cook, R.J., Heddle, N.M., Rebulla, P., Sigouin, C.S. & Webert, K.E. (2004) Methods for the analysis of bleeding outcomes in randomized trials of platelet transfusion triggers. Transfusion, 44, 1135-1142.
15. Delaney, M., Meyer, E., Cserti-Gazdewich, C., Haspel, R.L., Lin, Y., Morris, A., Pavenski, K., Dzik, W.H., Murphy, M., Slichter, S., Wang, G., Dumont, L.J. & Heddle, N. (2010) A systematic assessment of the quality of reporting for platelet transfusion studies. Transfusion, 50, 2135-2144.
16. 9 per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion, 45, 1064-1072.
17. Duke, W.W. (1910) The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and coagulation time and report of 3 cases of hemorrhagic disease relieved by transfusion. Journal of the American Medical Association, 55, 1185-1192.
18. Eder, A.F., Herron, R., Strupp, A., Dy, B., Notari, E.P., Chambers, L.A., Dodd, R.Y. & Benjamin, R.J. (2007) Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion, 47, 599-607.
19. Eldor, A., Avitzour, M., Or, R., Hanna, R. & Penchas, S. (1982) Prediction of haemorrhagic diathesis in thrombocytopenia by means of mean platelet volume. British Medical Journal, 285, 397-400.
20. Francis, J.J., Stockton, C., Eccles, M.P., Johnston, M., Cuthbertson, B.H., Grimshaw, J.M., Hyde, C., Tinmouth, A. & Stanworth, S.J. (2009a) Evidence-based selection of theories for designing behaviour change interventions: using methods based on theoretical construct domains to understand clinicians' blood transfusion behaviour. British Journal of Health Psychology, 14(Pt 4), 625-646.
21. Francis, J.J., Tinmouth, A., Stanworth, S.J., Grimshaw, J.M., Johnston, M., Hyde, C., Stockton, C., Brehaut, J.C., Fergusson, D. & Eccles, M.P. (2009b) Using theories of behaviour to understand transfusion prescribing in three clinical contexts in two countries: development work for an implementation trial. Implementation Science, 4, 70.
22. Friedmann, A.M., Sengul, H., Lehmann, H., Schwartz, C. & Goodman, S. (2002) Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? Transfusion Medicine Reviews, 16, 34-45.
23. Garg, A.X., Adhikari, N.K.J., McDonald, H., Rosas-Arellano, M.P., Devereaux, P.J., Beyene, J., Sam, J. & Haynes, R.B. (2005) Effects of computerised clinical decision support systems on practioner performance and patient outcomes. Journal of the American Medical Association, 293, 1223-1238.
24. Gaydos, L.A., Freireich, E.J. & Mantel, N. (1962) The quantitative relation between platelet count and hemorrhage in patients with acute leukaemia. New England Journal of Medicine, 266, 905-909.
25. Gerber, D.E., Segal, J.B., Levy, M.Y., Kane, J., Jones, R.J. & Streiff, M.B. (2008) The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood, 112, 504-510.
26. Gerday, E., Baer, V.L., Lambert, D.K., Pau, D.A., Sola-Visner, M.C., Pysher, T.J. & Christensen, R.D. (2009) Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion, 49, 2034-2039.
27. Gil-Fernández, J.J., Alegre, A., Fernández-Villalta, M.J., Pinilla, I., Gómez García, V., Martinez, C., Tomás, J.F., Arranz, R., A Figuera, A., R Cámara, R. & Fernández-Rañada, J.M. (1996) Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplantation, 18, 931-935.
28. Gmür, J., Burger, J., Schanz, U., Fehr, J. & Schaffner, A. (1991) Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. The Lancet, 338, 1223-1226.
29. Goerge, T., Ho-Tin-Noe, B., Carbo, C., Benerafa, C., Remold-O'Donell, E., Zhao, B.Q., Cifuni, S.M. & Wagner, D.D. (2008) Inflammation induces hemorrhage in thrombocytopenia. Blood, 111, 4958-4964.
30. Goodnough, L.T., Kuter, D.J., McCullough, J., Slichter, S.J., DiPersio, J., Romo, J., Peterson, R., Smith, K.J., Raife, T., Tomita, D. & Armstrong, S. (2001) Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood, 98, 1346-1351.
31. Greeno, E., McCullough, J. & Weisdorf, D. (2007) Platelet utilisation and the transfusion trigger: a prospective analysis. Transfusion, 47, 201-205.
32. Hanson, S.R. & Slichter, S.J. (1985) Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood, 66, 1105-1109.
33. Harrison, P., Ault, K.A., Chapman, S., Charie, L., Davis, B., Fujimoto, K., Houwen, B., Kunicka, J., Lacombe, F., Machin, S., Raynor, R., van Hove, L., van Assendelft, O.W. & International Society of Laboratory Hematology Task Force for the Reference Platelet Count (2001) An inter laboratory study of a candidate reference method for platelet counting. American Journal of Clinical Pathology, 115, 448-459.
34. Heal, J.M., Rowe, J.M., McMican, A., Masel, D., Finke, C. & Blumberg, N. (1993) The role of ABO matching in platelet transfusion. European Journal of Haematology, 50, 110-117.
35. 9/L. Journal of Clinical Oncology, 15, 1143-1149.
36. Heddle, N.M. & Webert, K.E. (2009) Investigation of acute transfusion reactions. In: Murphy M.F. & Pamphilon D.H. (eds). Practical Transfusion Medicine, 3rd edn, Wiley-Blackwell, Oxford: pp. 63-89.
37. Heddle, N.M. & Webert, K.E. (2009) Investigation of acute transfusion reactions. In: Practical Transfusion Medicine, 3rd edn (ed. by M.F. Murphy & D.H. Pamphilon), pp. 63-89. Wiley-Blackwell, Oxford.
38. Heddle, N.M., Cook, R.J., Webert, K.E., Sigouin, C. & Rebulla, P., in collaboration with the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society for Blood Transfusion (2003) Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion, 43, 742-752.
39. Heddle, N.M., Arnold, D.M., Boye, D., Webert, K.E., Resz, I. & Dumont, L.J. (2008) Comparing the efficacy and safety of apheresis and whole blood-derived platelet transfusions: a systematic review. Transfusion, 48, 1447-1458.
40. Heddle, N.M., Cook, R.J., Tinmouth, A., Kouroukis, C.T., Hervig, T., Klapper, E., Brandwein, J.M., Sczczepiorkowski, Z.M., AuBuchon, J.P., Barty, R.L., Lee, K.A. & for the StoP Study investigators of the BEST Collaborative (2009) A randomized controlled trial comparing standard and low dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood, 113, 1564-1573.
41. Higby, D.J., Cohen, E., Holland, J.F. & Sinks, L. (1974) The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study. Transfusion, 14, 440-445.
42. Higgins, J.P.T. & Green, S. (editors) (2008) Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1. The Cochrane Collaboration, 2008. Available from:. Accessed xx September 2008.
43. Janetzko, K., Cazenave, J.P., Klüter, H., Kientz, D., Michel, M., Beris, P., Lioure, B., Hastka, J., Marblie, S., Mayaudon, V., Lin, L., Lin, J.S., Conlan, M.G. & Flament, J. (2005) Therapeutic efficacy and safety of photochemically treated aphaeresis platelets processed with an optimized integrated set. Transfusion, 45, 1443-1452.
44. Josephson, C., Sloan, S., Granger, S., Castillejo, M., Strauss, R.G., Slichter, S., Steiner, M., Journeycake, J.M., Thornburg, C.D., Bussel, J., Grabowski, E.F. & Assmann, S. (2009) Increased incidence of grade 2 and higher bleeding in pediatric PLADO trial patients. Transfusion, 49(Suppl.), S42-020E.
45. Kerkhoffs, J.H.L., Eikenboom, J.C., Schipperus, M.S., van Wordragen-Vlaswinkel, R.J., Brand, R., Harvey, M.S., de Vries, R.R., Barge, R., van Rhenen, D.J. & Brand, A. (2006) A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood, 108, 3210-3215.
46. Kerkhoffs, J.L.H., van Putten, W.L.J., Novotny, V.M.J., Te Boekhorst, P.A.W., Schipperus, M.R., Zwaginga, J.J., van Pampus, L.C.M., de Greef, G.E., Luten, M., Huijgens, P.C., Brand, A., van Rhenen, D.J.; on behalf of the Dutch - Belgian HOVON cooperative group (2010) Clinical effectiveness of leucoreduced, pooled donor platelet concetrates, stored in plasma or additive solution with and without pathogen reduction. British Journal of Haematology, 150, 209-217.
47. Kitchens, C.S. & Weiss, L. (1975) Ultrastructural changes of endothelium associated with thrombocytopenia. Blood, 46, 567-578.
48. Klumpp, T.R., Herman, J.H., Gaughan, J.P., Russo, R.R., Christman, R.A., Goldberg, S.L., Ackerman, S.J., Bleecker, G.C. & Mangan, K.F. (1999) Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion, 39, 674-681.
49. Koreth, R., Weinert, C., Weisdorf, D.J. & Key, N.S. (2004) Measurement of bleeding severity: a critical review. Transfusion, 44, 605-617.
50. Larsen, O.H., Clausen, N., Persson, E., Ezban, M., Ingerslev, J. & Sørensen, B. (2009) Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue. British Journal of Haematology, 144, 99-106.
51. Lawrence, J.B., Yomtovian, R.A., Hammons, T., Masarik, S.R., Chongkowatana, V., Creger, R.J., Manka, A. & Lazarus, H.M. (2001) Lowering the prophylactic platelet transfusion threshold: a prospective analysis. Leukemia and Lymphoma, 41, 67-76.
52. Lee, E.J. & Schiffer, C.A. (1989) ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial. Transfusion, 29, 384-389.
53. Lin, Y.C., Chang, C.S., Yeh, C.J. & Wu, Y.C. (2010) The appropriateness and physician compliance of platelet usage by a computerized transfusion decision support system in a medical center. Transfusion, e-published prior to print publication. DOI:.
54. Liumbruno, G., Bennardello, F., Lattanzio, A., Piccoli, P., Rossetti, G., as Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) Working Party (2009) Recommendations for the transfusion of plasma and platelets. Blood Transfusion, 7, 132-150.
55. McCullough, J., Vesole, D.H., Benjamin, R.J., Slichter, S.J., Pineda, A., Snyder, E., Stadtmauer, E.A., Lopez-Plaza, I., Coutre, S., Strauss, R.G., Goodnough, L.T., Fridey, J.L., Raife, T., Cable, R., Murphy, S., Howard, F.I.V., Davis, K., Lin, J.S., Metzel, P., Corash, L., Koutsoukos, A., Lin, L., Buchholz, D.H. & Conlan, M.G. (2004) Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood, 104, 1534-1541.
56. Murphy, S., Litwin, S., Herring, L.M., Koch, P., Remischovky, J., Donaldson, M.H., Evans, A.E. & Gardner, F.H. (1982) Indications for platelet transfusion in children with acute leukemia. American Journal of Hematology, 12, 347-356.
57. Murphy, M.F., Navarrete, C. & Massey, E. (2009) Donor screening as a TRALI risk reduction strategy. Transfusion, 49, 1779-1782.
58. Nachman, R.L. & Rafii, S. (2008) Platelets, petechiae and preservation of the vascular wall. New England Journal of Medicine, 359, 1261-1270.
59. Najima, Y., Ohashi, K., Miyazawa, M., Nakano, M., Kobayashi, T., Yamashita, T., Akiyama, H. & Sakamaki, H. (2009) Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation. American Journal of Hematology, 84, 298-301.
60. 9 per L. Transfusion, 47, 801-812.
61. Norton, A., Kerr, J.P., O'Donovan, S., Edmondson, D., Cheesley, P., Stear, M., Massey, E.J. & Murphy, M.F. (2004) Variability in platelet dose and incremental response in haematology patients in the UK. British Journal of Haematology, 125(Suppl. 1), 64. Abstract.
62. Popovsky, M.A. & Moore, S.B. (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion, 25, 573-577.
63. Qureshi, H., Lowe, D., Dobson, P., Grant-Casey, J., Parris, E., Dalton, D., Hickling, K., Waller, F., Howell, C. & Murphy, M.F. (2007) National comparative audit of the use of platelet transfusions in the UK. Transfusion Clinique et Biologique, 14, 509-513.
64. Rebulla, P., Finazzi, G., Marangoni, F., Avvisati, G., Gugliotta, L., Tognoni, G., Barbui, T., Mandelli, F. & Sirchia, G. (1997) The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. New England Journal of Medicine, 337, 1870-1875.
65. Rothschild, J.M., McGurk, S., Honour, M., Lu, L., McClendon, A.A., Srivastava, P., Churchill, W.H., Kaufman, R.M., Avorn, J., Cook, E.F. & Bates, D.W. (2007) Assessment of education and computerised decision support interventions for improving transfusion practice. Transfusion, 47, 228-239.
66. Roy, A.J., Jaffe, N. & Djerassi, I. (1973) Prophylactic platelet transfusion in children with acute leukemia: a dose response study. Transfusion, 13, 283-290.
67. Schiffer, C.A., Anderson, K.C., Bennett, C.L., Bernstein, S., Elting, L.S., Goldsmith, M., Goldstein, M., Hume, H., McCullough, J.J., McIntyre, R.E., Powell, B.L., Rainey, J.M., Rowley, S.D., Rebulla, P., Troner, M.B. & Wagnon, A.H., for the American Society of Clinical Oncology (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19, 1519-1538.
68. Segal, H.C., Briggs, C., Kunka, S., Casbard, A., Harrison, P., Machin, S.J. & Murphy, M.F. (2005) Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. British Journal of Haematology, 128, 520-525.
69. Sensebe, L., Giraudeau, B., Baridaux, L., Deconinck, E., Schmidt, A., Bidet, M.L., LeNiger, C., Hardy, E., Babault, C. & Senecal, D. (2004) The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood, 105, 862-864.
70. Shehata, N., Tinmouth, A., Naglie, G., Freedman, J. & Wilson, K. (2009) ABO-identical versus non-identical platelet transfusion: a systematic review. Transfusion, 49, 2442-2453.
71. Silliman, C.C., Boshkov, L.K., Mehdizadehkashi, Z., Elzi, D.J., Dickey, W.O., Podlosky, L., Clarke, G. & Ambruso, D.R. (2003) Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood, 101, 454-462.
72. Slichter, S.J. (1980) Controversies in platelet transfusion therapy. Annual Reviews of Medicine, 31, 509-540.
73. Slichter, S.J. (2006) Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. Journal of Clinical Apheresis, 21, 78-84.
74. Slichter, S.J. (2007) Evidence-based platelet transfusion guidelines. Hematology (American Society of Hematology Education Program), 2007, 172-178.
75. Slichter, S.J. & Harker, L.A. (1978) Thrombocytopenia: mechanisms and management of defects in platelet production. Clinics in Haematology, 7, 523-539.
76. Slichter, S.J., Kaufman, R.M., Assmann, S.F., McCullough, J., Triulzi, D.J., Strauss, R.G., Gernsheimer, T.B., Ness, P.M., Brecher, M.E., Josephson, C.D., Konkle, B.A., Woodson, R.D., Ortel, T.L., Hillyer, C.D., Skerrett, D.L., McCrae, K.R., Sloan, S.R., Uhl, L., George, J.N., Aquino, V.M., Manno, C.S., McFarland, J.G., Hess, J.R., Leissinger, C. & Granger, S. (2010) Dose of prophylactic platelet transfusions and prevention of haemorrhage. New England Journal of Medicine, 362, 600-613.
77. Solomon, J., Bofenkamp, T., Fahey, J.L., Chillar, R.K. & Beutler, E. (1978) Platelet prophylaxis in acute non-lymphoblastic leukemia. The Lancet, 4, 267.
78. Stanworth, S.J., Hyde, C., Heddle, N., Rebulla, P., Brunskill, S. & Murphy, M.F. (2004) Prophylactic Platelet Transfusion for Haemorrhage after Chemotherapy and Stem Cell Transplantation. John Wiley & Sons, Ltd, Chichester, UK. The Cochrane Database of Systematic Reviews 2004, art no.: CD004269.pub2, doi:.
79. Stanworth, S.J., Dyer, C., Choo, L., Bakrania, L., Copplestone, A., Llewelyn, C., Norfolk, D., Powter, G., Littlewood, T., Wood, E.M. & Murphy, M.F., for the TOPPS Study Group (2010) Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions?: background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions. Transfusion Medicine Reviews, 24, 163-171.
80. Steffens, I., Harrison, J.F. & Taylor, C.P.F. (2002) A dose response study of platelet transfusion: comparison between triple dose apheresis platelet transfusion and three split standard transfusions. Haematologica, 87(Suppl. 1), Abstract.
81. Sullivan, M.T., McCullough, J., Schreiber, G.B. & Wallace, E.L. (2002) Blood collection and transfusion in the United States in 1997. Transfusion, 42, 1253-1260.
82. Taylor, C. (ed.), Cohen, H., Mold, D., Jones, H. et al, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group et al (2009) The 2008 Annual SHOT Report.
83. Taylor, C. (ed.), Cohen, H., Mold, D., Jones, H. et al, on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group (2010) The 2009 Annual SHOT Report.
84. Tinmouth, A.T. & Freedman, J. (2003) Prophylactic platelet transfusions: which dose is the best dose? A review of the literature Transfusion Medicine Reviews, 17, 181-193.
85. Tinmouth, A., Tannock, I.F., Crump, M., Tomlinson, G., Brandwein, J., Minden, M. & Sutton, D. (2004) Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor transplant and patients with acute leukaemia: a randomized controlled trial with a sequential Bayesian design. Transfusion Medicine, 44, 1711-1719.
86. Tinmouth, A., Macdougall, L., Fergusson, D., Amin, M., Graham, I.D., Hebert, P.C. & Wilson, K. (2005) Reducing the amount of blood transfused: a systematic review of behavioral interventions to change physicians' transfusion practices. Archives of Internal Medicine, 165, 845-852.
87. The Trial to reduce alloimmunization to platelets study group (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. New England Journal of Medicine, 337, 1861-1869.
88. Triulzi, D.J., Kleinman, S., Kakaiya, R.M., Busch, M.P., Norris, P.J., Steele, W.R., Glynn, S.A., Hillyer, C.D., Carey, P., Gottschall, J.L., Murphy, E.L., Rios, J.A., Ness, P.M., Wright, D.J., Carrick, D. & Schreiber, G.B.; Retrovirus Epidemiology in Donor Study II (2009a) The effects of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implication for a transfusion-related acute lung injury risk reduction strategy. Transfusion, 49, 1825-1835.
89. Triulzi, D.J., Assmann, S., Strauss, R.G., Ness, P.M., Hess, J.R., Granger, S. & Slichter, S.J. (2009b) Characteristics of transfused platelets do not affect bleeding outcomes in hypoproliferative thrombocytopenia. Blood, 114, 14. Abstract.
90. van de Watering, L. (2004) What has universal leucodepletion given us: evidence from clinical trials. Vox Sanguinis, 87(Suppl. 2), S139-S142.
91. van Rhenen, D., Gulliksson, H., Cazenave, J.P., Pamphilon, D., Ljungman, P., Klüter, H., Vermeij, H., Kappers-Klunne, M., de Greef, G., Laforet, M., Lioure, B., Davis, K., Marblie, S., Mayaudon, V., Flament, J., Conlan, M., Lin, L., Metzel, P., Buchholz, D. & Corash, L. (2003) Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euro SPRITE trial. Blood, 101, 2426-2433.
92. Verma, A., Pandey, P., Khetan, D. & Chaudhary, R. (2008) Platelet transfusions in clinical practice at a multidisciplinary hospital in North India. Transfusion and Apheresis Science, 39, 29-35.
93. 9/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukaemia. Blood, 91, 3601-3606.
94. Wandt, H., Schaefer-Eckart, K., Frank, M., Birkmann, J. & Wilhelm, M. (2006) A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation, 37, 387-392.
95. Wandt, H., Schaefer-Eckart, K., Pilz, B., Thalheimer, M., Ho, A.D., Schaich, M., Kaufmann, M., Aulitzky, W.E., Haenel, M., Herbst, R., Doelken, G., Klenner, A.F., Freund, M., Junghanss, C. & Ehninger, G. (2009a) Experience with a therapeutic platelet transfusion strategy in acute myeloid leukemia: preliminary results of a randomized multicenter study after enrolment of 175 patients. Blood, 113, 289-290a.
96. Wandt, H., Schäfer-Eckart, K., Wendelin, K., Rottmann, M., Thalmeimer, M., Schubert, M.S., Conradi, R., Schwerdtfeger, R., Leimer, L., Kaufmann, M., Klenner, A.F., Dölken, G., Schaich, M. & Ehninger, G. (2009b) A therapeutic platelet transfusion strategy without routine prophylactic transfusion is feasible and safe and reduces platelet transfusion numbers signifcantly: final analysis of a randomised study after high-dose chemotherapy and PBSCT. Bone Marrow Transplantation., 43(Suppl. 1s), S23.
97. Webert, K., Cook, R.J., Sigouin, C.S., Rebulla, P. & Heddle, N.M. (2006) The risk of bleeding in thrombocytopenic patients with acute myeloid leukemia. Haematologica, 91, 1530-1537.
98. Wells, A.W., Llewelyn, C.A., Casbard, A., Johnson, A.J., Amin, M., Ballard, S., Buck, J., Malfroy, M., Murphy, M.F. & Williamson, L.M. (2009) The EASTR study: a new approach to determine the reasons for transfusion in epidemiological studies. Transfusion Medicine, 19, 315-328.
99. WHO (1979) WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset publication No. 48, World Health Organization, Geneva.
100. Zumberg, M.S., del Roario, M.L., Nejame, C.F., Pollock, B.H., Garazarella, L., Kao, K.J., Lottenberg, R. & Wingard, J.R. (2002) A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant Recipients: 10, 000/μL versus 20, 000/μL Trigger. Biology of Blood and Marrow Transplantation, 8, 569-576.